|
86 Companies |
|
137 Products |
|
137 Products |
|
85 Mechanisms of Action |
|
4 Trials |
|
2019 News |
|
| «12...28293031323334353637383940 |
- |||| ABT-288 / AbbVie
Trial completion: Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia (clinicaltrials.gov) - Aug 10, 2011
P2, N=214, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Active, not recruiting --> Completed
- ||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
New P1 trial: Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder (clinicaltrials.gov) - Aug 7, 2011
P1, N=218, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.